Biktarvy, formally known as bictegravir, is a potent single-tablet therapy for controlling HIV infection. This drug combines three crucial antiviral agents: bictegravir, emtricitabine, and tenofovir alafenamide. It operates by inhibiting the the viral ability to multiply within the body, significantly decreasing the viral quantity. For many indiv